Spots Global Cancer Trial Database for Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

Official Title: Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

Study ID: NCT05629065

Conditions

Breast Cancer

Gastrointestinal Cancer

Gynecologic Cancer

Thoracic Cancer

Genitourinary Cancer

Interventions

Clinician Nudge Email

Patient Nudge Letter and Share questionaire

Study Description

Brief Summary: The purpose of this study is to increase serious illness conversations (SICs) about patients goals and preferences regarding their healthcare between patients with cancer and their oncology clinicians and improved care provided near the end of life.

Detailed Description: The objective of this study is to implement an intervention in a pragmatic randomized controlled trial that uses cancer treatment pathways data to identify patients appropriate for serious illness conversations (SICs) and applies "nudges" to patients and their oncology clinicians to increase SICs and improve end of life (EOL) outcomes. Identified participants and clinicians will be randomized into 1 or 4 groups. * Nudge to patient and clinician * Nudge to patient only * Nudge to clinician only * No nudge. The expected enrollment is approximately 800 participants.